Playing from staycurrentmd
6 views 0 likes

StayCurrentMD

GCMD Space · View profile →

Characteristics of Transfusion and Association With Oncologic Outcomes in Hepatoblastoma Resection

Video Published 2026-04-10 Updated 2026-08-01

Timestops (3)

Topic Overview

A single-speaker summary of a 2025 multi-institutional study published in Pediatric Blood and Cancer examining the relationship between intraoperative transfusion and oncologic outcomes in hepatoblastoma resection. The study found that while transfusion did not affect recurrence, it was associated with increased mortality. The authors identified instances of unnecessary transfusion and postoperative coagulopathy, recommending more selective transfusion practices and balanced transfusion protocols.

Key Takeaways

  • Intraoperative transfusion in hepatoblastoma resection associated with increased mortality but not recurrence. (0:32)
  • RBC-predominant transfusion may contribute to postoperative coagulopathy requiring additional plasma and platelets. (0:25)
  • Unnecessary transfusions occurred; more selective patient selection and balanced transfusion protocols recommended. (0:39)

Inside this episode

Kai, the Library's AI content creator, listened to this episode and mapped who's speaking, the chapters, key claims, and cases. Every item links to the exact moment in the recording.

AI-enriched

Who's speaking

  • Jill Kneroth — host

Chapters

  • 0:00Introduction and Study Context — Introduction to the clinical question of whether intraoperative transfusion during hepatoblastoma resection affects oncologic outcomes, and identification of the source study.
  • 0:24Study Findings — Key results including transfusion patterns, effects on recurrence and mortality, and evidence of unnecessary transfusions and postoperative complications.
  • 0:51Author Recommendations — Authors' interpretation linking red blood cell-predominant transfusion to coagulopathy and recommendations for improved transfusion practice.

Key claims

  • 0:00It is not uncommon for a patient with hepatoblastoma to need a transfusion during resection — Jill Kneroth
  • 0:13The study was multi-institutional and published in Pediatric Blood and Cancer in 2025 — Jill Kneroth
  • 0:19The study examined how intraoperative transfusion may affect recurrence and survival in hepatoblastoma resection patients — Jill Kneroth
  • 0:25Of those transfused, the majority received red blood cells — Jill Kneroth
  • 0:25Only 11% of transfused patients received platelets — Jill Kneroth
  • 0:32Intraoperative blood transfusions had no effect on recurrence — Jill Kneroth
  • 0:32Intraoperative blood transfusions were associated with increased death — Jill Kneroth
  • 0:39There were instances of unnecessary blood transfusions — Jill Kneroth
  • 0:43Patients who were transfused had higher post-op hemoglobin — Jill Kneroth
  • 0:43Transfused patients still required more plasma and platelets postoperatively — Jill Kneroth
  • 0:52The authors think that blood transfusions were mostly red blood cells, and that is what contributed to the post-op coagulopathy — Jill Kneroth
  • 1:00The authors recommend more careful patient selection for intraoperative transfusions — Jill Kneroth
  • 1:00The authors recommend a balanced transfusion approach — Jill Kneroth

Open questions

  • Does this change the way you see intraoperative transfusions?
This episode was analyzed and enriched by Kai, the Library's AI content creator. Every item links to the moment it comes from — click a timestamp to listen in context.

Keywords

Hashtags

Transcript

Comments

Loading comments…